Perrigo (PRGO) Share-based Compensation (QoQ) (2013 - 2026)
Perrigo (PRGO) Share-based Compensation (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Perrigo | 1.98 Bn | 1.58 Bn | 313.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -52.78% |
| Mar 28, 2026 | 4,700.00% |
| Dec 31, 2025 | 103.13% |
| Sep 27, 2025 | -158.18% |
| Jun 28, 2025 | 38.66% |
| Mar 29, 2025 | 2,280.00% |
| Dec 31, 2024 | 102.12% |
| Sep 28, 2024 | -202.61% |
| Jun 29, 2024 | 47.44% |
| Mar 30, 2024 | 47.17% |
| Dec 31, 2023 | -27.89% |
| Sep 30, 2023 | -20.97% |
| Jul 1, 2023 | -25.30% |
| Apr 1, 2023 | 203.66% |
| Dec 31, 2022 | -12.77% |
| Oct 1, 2022 | -14.55% |
| Jul 2, 2022 | -58.17% |
| Apr 2, 2022 | 165.66% |
| Dec 31, 2021 | -10.81% |
| Oct 2, 2021 | -21.28% |